|
N-{(1S,2S,3R)-1-[(alpha-D-galactopyranosyloxy)methyl]- 2,3-dihydroxyheptadecyl}-15-phenylpentadecanamide
|
139168 |
|
|
N-{(1S,2S,3R)-1-[(alpha-D-galactopyranosyloxy)methyl]- 2,3-dihydroxyheptadecyl}-21-phenylhenicosanamide
|
139169 |
|
|
N-{(1S,2S,3R)-1-[(alpha-D-galactopyranosyloxy)methyl]- 2,3-dihydroxyheptadecyl}-25-phenylpentacosanamide
|
139170 |
|
|
N-{(1S,2S,3R)-1-[(alpha-D-galactopyranosyloxy)methyl]- 2,3-dihydroxyheptadecyl}-6-(4-methoxyphenyl)hexanamide
|
139174 |
|
|
6-(4-fluorophenyl)-N-{(1S,2S,3R)-1-[(alpha-D-galactopyranosyloxy)methyl]- 2,3-dihydroxyheptadecyl}hexanamide
|
139175 |
|
|
(S)-13-(cyclopent-2-en-1-yl)tridecanoic acid
|
61391 |
|
|
(S)-2-Cyclopentene-1-tridecanoic acid
|
61391 |
|
|
13-(S)-cyclopent-2-enyl-tridecanoic acid
|
61391 |
|
|
13-[(S)-cyclopent-2-enyl]-tridecanoic acid
|
61391 |
|
|
EC 2.4.1.255 (protein O-GlcNAc transferase) inhibitors
|
139153 |
|
|
beta-D-mannosyl phosphomycoketide C32
|
139143 |
|
